Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisli Jenkins

Showing results (131-140 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 19, 2024
<i>TOLLIP</i> SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary FibrosisWilliam Whalen, Kristin Berger, John S Kim, et al.
The Journal of Biological Chemistry|February 11, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 ExpressionAmanda L Tatler, Anthony Habgood, Joanne Porte, et al.
The European Respiratory Journal|January 8, 2022
Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodellingJopeth Ramis, Robert Middlewick, Francesco Pappalardo, et al.
American Journal of Respiratory and Critical Care Medicine|January 2, 2025
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung DiseaseKerri A Johannson, Ayodeji Adegunsoye, Jürgen Behr, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
The European Respiratory Journal|April 20, 2023
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation studyCarl J Reynolds, Fabiola Del Greco M, Richard J Allen, et al.
Ebiomedicine|October 20, 2022
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosisMaurizio Chioccioli, Subhadeep Roy, Rachel Newell, et al.
Annals of the American Thoracic Society|September 13, 2023
Approach to Clinical Trials for the Prevention of Pulmonary FibrosisJohn S Kim, Sydney B Montesi, Ayodeji Adegunsoye, et al.
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Thorax|May 9, 2022
Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosisLuke M Kraven, Adam R Taylor, Philip L Molyneaux, et al.
Pageof 21

Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Respiratory and Critical Care Medicine|May 19, 2024
<i>TOLLIP</i> SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary FibrosisWilliam Whalen, Kristin Berger, John S Kim, et al.
The Journal of Biological Chemistry|February 11, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 ExpressionAmanda L Tatler, Anthony Habgood, Joanne Porte, et al.
The European Respiratory Journal|January 8, 2022
Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodellingJopeth Ramis, Robert Middlewick, Francesco Pappalardo, et al.
American Journal of Respiratory and Critical Care Medicine|January 2, 2025
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung DiseaseKerri A Johannson, Ayodeji Adegunsoye, Jürgen Behr, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
The European Respiratory Journal|April 20, 2023
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation studyCarl J Reynolds, Fabiola Del Greco M, Richard J Allen, et al.
Ebiomedicine|October 20, 2022
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosisMaurizio Chioccioli, Subhadeep Roy, Rachel Newell, et al.
Annals of the American Thoracic Society|September 13, 2023
Approach to Clinical Trials for the Prevention of Pulmonary FibrosisJohn S Kim, Sydney B Montesi, Ayodeji Adegunsoye, et al.
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Thorax|May 9, 2022
Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosisLuke M Kraven, Adam R Taylor, Philip L Molyneaux, et al.
Pageof 21